Today’s teasers come in from Mark Skousen, who edits the Forecasts & Strategies newsletter and has graced our pages a few times in the past — most recently when he touted Cubist Pharmaceuticals very aggressively as a “winning lottery ticket” and “superbug killer” (that one did quite well, thanks to both the FDA and a [...]
Mark Skousen, who is one of those Ph.D-type doctors (economics) and thankfully doesn’t always insist on being called Dr. Skousen (yes, we’re looking at you Dr. Leeb), is pitching a health care stock today as a teaser for his Forecasts and Strategies newsletter. And like some folks we’ve heard from in the past, he’s teasing [...]
I don’t write about Mark Skousen all that often, in part because he doesn’t regularly barrage us with detailed stock teasers … but I’ve had a lot of readers write in to ask me about this latest teaser ad for his Forecasts and Strategies newsletter, an ad in which he says his favorite stock kept [...]
On this bright and sunny Spring day our thoughts turn … to Mark Skousen. He’s selling subscriptions to his Forecasts & Strategies newsletter, and his pitch is that he predicted the 1980s boom, and warned investors that corporate profits were peaking in early 2007 … and that he’s got the best ideas for you to [...]
I mentioned that I wanted to get to this one today — it’s probably not in time for most of you to catch it in the Monday email alert, but here it is anyway. Mark Skousen is touting a bank stock for his Forecasts and Strategies newsletter, and more specifically he’s predicting that the bank [...]
Taking a brief break from dissecting Ann Sosnowski’s latest 13F teasers, we move along to look at one that just started cropping up in my inbox from Mark Skousen and his Forecasts and Strategies newsletter. I’ve looked at lots of Skousen’s teasers before — he has picked some good ones like China Medical, which he [...]
Many of you saw this email last week, the latest in a long string of Mark Skousen’s attempts to predict breakout stock performance on earnings dates. His past history of this is spotty, and I’ve written a few times about earnings pops he has predicted — some good, some bad. Alas, I didn’t get a [...]
I’ve written about various teasers from Mark Skousen’s services several times over the last year or so, and he is, at least, always confident. He has teased several good stocks that have performed well, including Sadia, ABB, and CVRD, and several that have stunk — like Volcano and Centerline Holdings (to be fair, I thought [...]
Ah, it’s so nice to have a lovely little sleuthing job to distract me … this is much more enjoyable than watching my own portfolio tick lower, or watching the market indexes crawl frantically into into the basement like scared children in a horror movie. Enough distractions like this, and I can actually follow through [...]
This one was sent in by a reader, along with a suggestion for the solution (which, as so often with the Gumshoe’s readers, appears to be correct). It’s from Mark Skousen in the form of an ad for Forecasts and Strategies, and, as you have guessed from the title of this note, it’s about a [...]
Here’s one that was sent in by a reader a little while ago — it’s for Mark Skousen’s Forecasts & Strategies, which we’ve seen before a few times (the last pick we sleuthed out, China Medical, did pretty well for him). And this is another medical technology stock, so perhaps it warrants some attention. The [...]
This teaser was posted over at the forum a little while ago, and though I haven’t actually seen the original email the poster said it was sent out yesterday. It’s from Mark Skousen’s Forecasts & Strategies service, which we’ve come across several times before, and it touts a company that has recently seen over $9.3 [...]
“A young company, along with one of the world’s largest universities, has created a successful, non-invasive system for the treatment of nature’s deadliest disease.” That’s how Mark Skousen opens his ad for his newsletter, Forecasts and Strategies. If you wan to see what the company is, you’ll have to sign up for a subscription … [...]
